Skip to search.
 STI Up 2.53%

Biogen Inc. (BIIB)

-NasdaqGS
263.86 Down 9.41(3.44%) 6 Feb 05:00 SGT
|After Hours : 263.50 Down 0.36 (0.14%) 6 Feb 07:37 SGT
Prev Close:273.27
Open:271.10
Bid:262.32 x 100
Ask:269.00 x 300
1y Target Est:354.94
Beta:0.512311
Earnings Date:22 Apr - 26 Apr (Est.)
Day's Range:258.46 - 272.67
52wk Range:254.00 - 480.18
Volume:2,856,944
Avg Vol (3m):1,864,430
Market Cap:57.70B
P/E (ttm):17.20
EPS (ttm):15.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 3.44%57.70B
PFEUp 0.10%179.22B
ABTDown 1.58%55.81B

Key Statistics

Forward P/E (1 yr):13.11
P/S (ttm):5.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :18.63
Quarterly EPS Est (Mar-16) :4.46
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback